Goldberg, T. E., Lee, S., Devanand, D., & Schneider, L. S. S. (2024). Comparison of Relative Change with Effect Size Metrics in Alzheimer’s Disease Anti‐amyloid Clinical Trials. Alzheimer’s & Dementia, 20(S8). Portico. https://doi.org/10.1002/alz.094862

Leuva, H., Zhou, M., Jamaleddine, N., Meseha, M., Faiena, I., Anna Park, Y.-H., McWilliams, G., Luhrs, C., Maxwell, K. N., Von Hoff, D., Bates, S. E., & Fojo, T. (2024). Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent -rate method ideal for real-world analyses. EBioMedicine, 107, 105288. https://doi.org/10.1016/j.ebiom.2024.105288

Zhang, L., Richter, L. R., Wang, Y., Ostropolets, A., Elhadad, N., Blei, D. M., & Hripcsak, G. (2024). Causal fairness assessment of treatment allocation with electronic health records. Journal of Biomedical Informatics, 155, 104656. https://doi.org/10.1016/j.jbi.2024.104656

Fojo, T., LaRose, M., & Bates, S. E. (2024). The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype. The Oncologist, 29(4), 275–277. https://doi.org/10.1093/oncolo/oyae042

He, P., Gambhire, D., Zhou, H., Ma, X., Emura, Y., Laadem, A., Leung, D., Bates, S. E., Fojo, A. T., & Rixe, O. (2024). 76P Utilization of g score in early oncology drug development: Impact on study design and early go/no-go decision. ESMO Open, 9, 102304. https://doi.org/10.1016/j.esmoop.2024.102304

Goldberg, T. E., Lee, S., Devanand, D. P., & Schneider, L. S. (2023). Comparison of relative change with effect size metrics in Alzheimer’s disease clinical trials. Journal of Neurology, Neurosurgery & Psychiatry, 95(1), 2–7. https://doi.org/10.1136/jnnp-2023-331941

Najjar, M., McCarron, J., Cliff, E. R. S., Berger, K., Steensma, D. P., Al Hadidi, S., Chakraborty, R., Goodman, A., Anto, E., Greene, T., Sborov, D., & Mohyuddin, G. R. (2023). Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma. JAMA Network Open, 6(11), e2342195. https://doi.org/10.1001/jamanetworkopen.2023.42195

Wu, Q., Schuemie, M. J., Suchard, M. A., Ryan, P., Hripcsak, G. M., Rohde, C. A., & Chen, Y. (2023). Padé approximant meets federated learning: A nearly lossless, one-shot algorithm for evidence synthesis in distributed research networks with rare outcomes. Journal of Biomedical Informatics, 145, 104476. https://doi.org/10.1016/j.jbi.2023.104476

Buxton, M., Alexander, B., Berry, D., Cavenee, W., Colman, H., de Groot, J., Ellingson, B., Gordon, G., Khasraw, M., Lassman, A., Lee, E., Li, W., Lim, M., Mellinghoff, I., Mikkelsen, T., Nelli, A., Perry, J., Sulman, E., Tanner, K., … Cloughesy, T. (2022). CTNI-38. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. Neuro-Oncology, 24(Supplement_7), vii80–vii80. https://doi.org/10.1093/neuonc/noac209.303

Mazza, G. L., Petersen, M. M., Ginos, B., Langlais, B. T., Heon, N., Gounder, M. M., Mahoney, M. R., Zoroufy, A. J., Schwartz, G. K., Rogak, L. J., Thanarajasingam, G., Basch, E., & Dueck, A. C. (2021). Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2. Quality of Life Research, 31(4), 1069–1080. https://doi.org/10.1007/s11136-021-02968-1

Yap, C., Solovyeva, O., Yin, Z., Martin, J., Manickavasagar, T., Weir, C., Lee, S., Dimairo, M., Liu, R., Kightley, A., & de Bono, J. S. (2022). 53P Assessing the reporting quality of early phase dose-finding trials. Annals of Oncology, 33, S24. https://doi.org/10.1016/j.annonc.2022.01.018

Parisien, R. L., Trofa, D. P., Cronin, P. K., Dashe, J., Curry, E. J., Eichinger, J. K., Levine, W. N., Tornetta, P., & Li, X. (2021). Comparative Studies in the Shoulder Literature Lack Statistical Robustness: A Fragility Analysis. Arthroscopy, Sports Medicine, and Rehabilitation, 3(6), e1899–e1904. https://doi.org/10.1016/j.asmr.2021.08.017